FDA.reportPublic FDA data

brimonidine 0.33 % Topical Gel

RxCUI
1437707
RxNorm name
brimonidine 0.33 % Topical Gel
Display name
brimonidine 0.33 % Topical Gel
Full name
brimonidine 0.33 % Topical Gel
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MirvasoBRIMONIDINE TARTRATEGalderma Laboratories, L.P.f6a4353f-ae69-4214-901f-e5d42a6fbde72024-10-24Warnings, Adverse reactionsExact identifier
rxcui: 1437707
BRIMONIDINEBRIMONIDINEPadagis Israel Pharmaceuticals Ltdc899b329-cc5e-4443-8e94-451314de47c92024-07-31Warnings, Adverse reactionsExact identifier
rxcui: 1437707
BRIMONIDINEBRIMONIDINEBryant Ranch Prepack9f17bf0c-d880-4328-bf92-00ac81d02fd12023-02-03Warnings, Adverse reactionsExact identifier
rxcui: 1437707

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9f17bf0c-d880-4328-bf92-00ac81d02fd1brimonidine 0.33 % Topical GelPSN100These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 199620230203
9f17bf0c-d880-4328-bf92-00ac81d02fd1brimonidine 0.0033 MG/MG Topical GelSCD100These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 199620230203
9f17bf0c-d880-4328-bf92-00ac81d02fd1brimonidine 0.33 % (as brimonidine tartrate) Topical GelSY100These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 199620230203
f6a4353f-ae69-4214-901f-e5d42a6fbde7brimonidine 0.33 % Topical GelPSN11These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 199620241024
f6a4353f-ae69-4214-901f-e5d42a6fbde7brimonidine 0.33 % (as brimonidine tartrate) Topical GelSY11These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 199620241024
f6a4353f-ae69-4214-901f-e5d42a6fbde7brimonidine 0.0033 MG/MG Topical GelSCD11These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 199620241024
c899b329-cc5e-4443-8e94-451314de47c9brimonidine 0.33 % (as brimonidine tartrate) Topical GelSY4These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 199620240731
c899b329-cc5e-4443-8e94-451314de47c9brimonidine 0.33 % Topical GelPSN4These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 199620240731
c899b329-cc5e-4443-8e94-451314de47c9brimonidine 0.0033 MG/MG Topical GelSCD4These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 199620240731